User menu

Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.

Bibliographic reference Horsmans, Yves ; Solbreux, P M ; Daenens, C. ; Desager, Jean-Pierre ; Geubel, André. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.. In: Alimentary pharmacology & therapeutics, Vol. 11, no. 1, p. 165-70 (1997)
Permanent URL http://hdl.handle.net/2078.1/23040
  1. 1 Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3 : 75-82.
  2. 2 Gitlin N. Subclinical portal-systemic encephalopathy. Am J Gastroenterol 1988; 83 : 64-7.
  3. 3 Gilberstadt SJ, Gilberstadt H, Zieve L,et al. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980; 140 : 519-21.
  4. 4 Schomerus H, Hamster W, Blunck H,et al. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981; 26 : 622-30.
  5. 5 Loguercio C, Del Vecchio-Blanco C, Coltorti M. Psychometric tests and 'latent' portal systemic encephalopathy. Br J Clin Pract 1984; 38 : 407-11.
  6. 6 Loguercio C, Abbiati K, Rinaldi M,et al. Long-term effects of Enterococcus faecium SF 68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. J Hepatol 1995; 23 : 39-46.
  7. 7 Bircher J, Muller J, Guggenheim P, Haemmerli VP. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1966; 1 : 890-3.
  8. 8 Lanthier PL, Morgan MY. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut 1985; 26 : 415-20.
  9. 9 Morgan MY, Hawley KE. Lactitol versus lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Hepatology 1987; 7 : 1278-84.
  10. 10 Morgan MY, Hawley KE, Stambuk D. Lactitol vs. lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomized, cross-over study. J Hepatol 1987; 4 : 236-44.
  11. 11 Morgan MY, Alonso M, Stanger LC. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study. J Hepatol 1989; 98 : 208-17.
  12. 12 Mc Clain CJ, Potter TJ, Kromhout JP, Zieve L. The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy. J Clin Gastroenterol 1984; 6 : 325-9.
  13. 13 Heredia D, Caballeria J, Arroyo V,et al. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial. J Hepatol 1987; 4 : 293-8.
  14. 14 Riggio O, Balducci G, Ariosto F,et al. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Dig Dis Sci 1989; 34 : 823-9.
  15. 15 Schomerus H, Schreiegg J. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 1993; 31 : 231-4.
  16. 16 Miller GE, Rice JD. Determination of the concentration of ammonia nitrogen in plasma by means of a simple ion exchange method. Am J Clin Pathol 1963; 39 : 97-103.
  17. 17 Bremer HJ, Duran M, Kamerling JP,et al. Disturbances of Amino Acid Metabolism: Clinical Chemistry and Diagnosis. Baltimore/Munich: Urban & Schwarzenberg, 1981 451-65.
  18. 18 Pauwels S, Geubel AP, Dive C, Beckers C. Breath14CO2after intravenous administration of14C aminopyrine in liver diseases. Dig Dis Sci 1982; 27 : 49-56.
  19. 19 Horsmans Y, Desager JP, Daenens C,et al. D-propoxyphene and norpropoxyphene kinetics after the oral administration ofD-propoxyphene: a new approach to liver function? J Hepatol 1994; 21 : 283-91.
  20. 20 Cleeman M. Gas chromatographic determination of propoxyphene and norpropoxyphene in plasma. J Chromatography 1977; 132 : 287-94.
  21. 21 Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22 : 541-50.
  22. 22 Douwes AC, Van Der Burg GJ, Bouman AA,et al. Lactitol, lactulose, and blood ammonia. Lancet 1987; 2 : 688.
  23. 23 Herrmann R, Wezber FL Jr. Lactulose and ammonia. Table 2. Biochemical data, P450 microsomal function and degree of shunting in 14 patients with cirrhosis and without hepatic encephalopathy before and after 15 days of treatment with placebo or lactulose. Lancet 1987; ii: 1333.
  24. 24 Kugler CFA, Lotterer E, Petter J,et al. Visual event-related P300 potentials in early portosystemic encephalopathy. Gastroenterology 1992; 103 : 302-10.
  25. 25 Zeneroli ML, Pinelli G, Gollini G,et al. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. Gut 1984; 25 : 291-9.
  26. 26 Yen CL, Lian YF. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepatogastroenterol 1990; 37 : 332-4.
  27. 27 O'Caroll RE, Hayes PC, Ebmeier KP,et al. Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 1991; 337 : 1250-3.